Commonwealth Equity Services’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-966
Closed -$10K 4104
2024
Q3
$10K Sell
966
-459
-32% -$7.63K ﹤0.01% 4028
2024
Q2
$28K Hold
1,425
﹤0.01% 3947
2024
Q1
$36K Buy
1,425
+720
+102% +$18.5K ﹤0.01% 3925
2023
Q4
$19K Buy
+705
New +$43K ﹤0.01% 3820
2023
Q1
Sell
-687
Closed -$95K 3783
2022
Q4
$95K Buy
+687
New +$96.8K ﹤0.01% 3421
2020
Q1
Sell
-275
Closed -$312K 2829
2019
Q4
$312K Sell
275
-45
-14% -$48.9K ﹤0.01% 2282
2019
Q3
$380K Buy
320
+27
+9% +$41.2K ﹤0.01% 2042
2019
Q2
$482K Buy
293
+18
+7% +$31.1K ﹤0.01% 1826
2019
Q1
$560K Sell
275
-25
-8% -$44K ﹤0.01% 1668
2018
Q4
$385K Buy
300
+110
+58% +$169K ﹤0.01% 1836
2018
Q3
$358K Buy
190
+18
+10% +$37.2K ﹤0.01% 2028
2018
Q2
$349K Buy
172
+23
+15% +$52.4K ﹤0.01% 1997
2018
Q1
$330K Buy
149
+29
+24% +$73.8K ﹤0.01% 1996
2017
Q4
$277K Buy
+120
New +$244K ﹤0.01% 2096

Other funds holding BLUE

Commonwealth Equity Services's BLUE Position: Q4 2024 in Review

Commonwealth Equity Services sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 966 shares — an estimated $10K sold.

Commonwealth Equity Services first reported a position in BLUE in Q4 2017 and held it in 14 quarters. The position peaked at $560K in Q1 2019. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Commonwealth Equity Services reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 966 bluebird bio shares in Q4 2024, an estimated $10K.
  • Commonwealth Equity Services first reported a position in bluebird bio in Q4 2017 and held it in 14 quarters.
  • Commonwealth Equity Services's bluebird bio position peaked at $560K in Q1 2019.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Commonwealth Equity Services's 13F filing for Q4 2024, filed 10 Feb 2025.